Literature DB >> 23933538

The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.

Amit V Khera1, Parin J Patel, Muredach P Reilly, Daniel J Rader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23933538     DOI： 10.1016/j.jacc.2013.07.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  27 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.

Authors:  Graziella E Ronsein; Patrick M Hutchins; Daniel Isquith; Tomas Vaisar; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

Review 3.  Clinical and biological relevance of statin-mediated changes in HDL metabolism.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 4.  Niacin for primary and secondary prevention of cardiovascular events.

Authors:  Stefan Schandelmaier; Matthias Briel; Ramon Saccilotto; Kelechi K Olu; Armon Arpagaus; Lars G Hemkens; Alain J Nordmann
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

5.  Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified.

Authors:  Ali Javaheri; Daniel J Rader
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

Review 6.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 7.  Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?

Authors:  Preethi Mani; Anand Rohatgi
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

8.  Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Authors:  Tina Costacou; Andrew P Levy; Rachel G Miller; Janet Snell-Bergeon; Rabea Asleh; Dan Farbstein; Catherine E Fickley; Georgia Pambianco; Rona de la Vega; Rhobert W Evans; Trevor J Orchard
Journal:  Acta Diabetol       Date:  2015-05-24       Impact factor: 4.280

Review 9.  Role of HDL in those with diabetes.

Authors:  Carlos G Santos-Gallego; Robert S Rosenson
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

Review 10.  Dysfunctional HDL and atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Nat Rev Cardiol       Date:  2015-09-01       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.